259 related articles for article (PubMed ID: 36443676)
1. Deep learning and multi-omics approach to predict drug responses in cancer.
Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
[TBL] [Abstract][Full Text] [Related]
2. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
Park S; Soh J; Lee H
BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
[TBL] [Abstract][Full Text] [Related]
3. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
Pang W; Chen M; Qin Y
BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
[TBL] [Abstract][Full Text] [Related]
4. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
[TBL] [Abstract][Full Text] [Related]
5. SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures.
Zuo Z; Wang P; Chen X; Tian L; Ge H; Qian D
BMC Bioinformatics; 2021 Sep; 22(1):434. PubMed ID: 34507532
[TBL] [Abstract][Full Text] [Related]
6. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
Tong L; Mitchel J; Chatlin K; Wang MD
BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
[TBL] [Abstract][Full Text] [Related]
7. Gene-centric multi-omics integration with convolutional encoders for cancer drug response prediction.
Lee M; Kim PJ; Joe H; Kim HG
Comput Biol Med; 2022 Dec; 151(Pt A):106192. PubMed ID: 36327883
[TBL] [Abstract][Full Text] [Related]
8. Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches.
Liu XY; Mei XY
Front Bioeng Biotechnol; 2023; 11():1156372. PubMed ID: 37139048
[TBL] [Abstract][Full Text] [Related]
9. De novo Prediction of Cell-Drug Sensitivities Using Deep Learning-based Graph Regularized Matrix Factorization.
Ren S; Tao Y; Yu K; Xue Y; Schwartz R; Lu X
Pac Symp Biocomput; 2022; 27():278-289. PubMed ID: 34890156
[TBL] [Abstract][Full Text] [Related]
10. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
Li Y; Guo Z; Gao X; Wang G
Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
[TBL] [Abstract][Full Text] [Related]
11. DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines.
Li M; Wang Y; Zheng R; Shi X; Li Y; Wu FX; Wang J
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):575-582. PubMed ID: 31150344
[TBL] [Abstract][Full Text] [Related]
12. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
13. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
Peng W; Chen T; Dai W
IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
[TBL] [Abstract][Full Text] [Related]
14. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
Malik V; Kalakoti Y; Sundar D
BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
[TBL] [Abstract][Full Text] [Related]
15. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
Tong L; Wu H; Wang MD
Methods; 2021 May; 189():74-85. PubMed ID: 32763377
[TBL] [Abstract][Full Text] [Related]
16. Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.
Zhu J; Oh JH; Simhal AK; Elkin R; Norton L; Deasy JO; Tannenbaum A
Comput Biol Med; 2023 Sep; 163():107117. PubMed ID: 37329617
[TBL] [Abstract][Full Text] [Related]
17. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
18. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
[TBL] [Abstract][Full Text] [Related]
19. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
20. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
